Section Arrow
Quote
SLGL.NASDAQ
- Sol-Gel Technologies Ltd
Quotes are at least 15-min delayed:2026/11/04 20:55 EST
Regular Hours
Last
 66
+2.19 (+3.43%)
Day High 
67.5 
Prev. Close
63.81 
1-M High
79.5 
Volume 
40.35K 
Bid
65.25
Ask
66.35
Day Low
63.3 
Open
63.82 
1-M Low
62.66 
Market Cap 
208.91M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 67.51 
20-SMA 68.15 
50-SMA 68.52 
52-W High 97.36 
52-W Low 28.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.62/-4.92
Enterprise Value
209.41M
Balance Sheet
Book Value Per Share
14.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.39M
Operating Revenue Per Share
0.38
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.11+0.3961+55.48%0.2PE
KPTIKaryopharm Therapeutics Inc.0.0729-0.0154-17.44%-- 
GERNGeron Corp1.08+0.15+16.13%-- 
INOInovio Pharmaceuticals1.62-0.04-2.41%-- 
RXRXRecursion Pharmaceuticals3.88+0.2+5.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includesSGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease andother rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.